tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Andrew Paine, 3 are a BUY (100%).
Analyst Andrew Paine, currently employed at CLSA,
Andrew Paine’s has documented 8 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RMD, ResMed at 14-Oct-2022.
Analyst best performing recommendations are on RMD (RESMED).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Oct-2025
$215
$-16.52 (-7.14%)
$225
Buy Since 06-Feb-2024
$255
$23.48 (10.14%)
$290
Hold Since 07-Aug-2026
$244
$12.48 (5.39%)
$234
Hold Since 10-Jan-2025
$225
$-6.52 (-2.82%)
$275
Buy Since 14-Apr-2023
$220
$-11.52 (-4.98%)
$300
What Year was the first public recommendation made by Andrew Paine?
